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Abstract 1 
Biodegradable scaffold matrixes form the basis of any in vitro tissue engineering approach by acting as 2 
a temporary matrix for cell proliferation and extracellular matrix deposition until the scaffold is replaced 3 
by neo-tissue. In this context several synthetic polymers have been investigated, however a concise 4 
systematic comparative analyses is missing. Therefore, the present study systematically compares three 5 
frequently used polymers for the in vitro engineering of extracellular matrix based on poly-glycolic acid 6 
(PGA) under static as well as dynamic conditions. Ultra-structural analysis was used to examine the 7 
polymers structure. For tissue engineering (TE) three human fibroblast cell lines were seeded on either 8 
PGA-poly-4-hydroxybutyrate (P4HB), PGA-poly-lactic acid (PLA) or PGA-poly–caprolactone (PCL) 9 
patches. These patches were analyzed after 21 days of culture qualitative by histology and quantitative 10 
by determining the amount of DNA, glycosaminoglycan and hydroxyproline. We found that PGA-P4HB 11 
and PGA-PLA scaffolds enhance tissue formation significantly higher than PGA-PCL scaffolds 12 
(p<0.05). Polymer remnants were visualized by polarization microscopy. In addition, biomechanical 13 
properties of the tissue engineered patches were determined in comparison to native tissue. This study 14 
may allow future studies to specifically select certain polymer starter matrices aiming at specific tissue 15 
properties of the bioengineered constructs in vitro. 16 
 17 
Introduction 18 
During the last years, the interdisciplinary field of tissue engineering (TE) has emerged as a platform 19 
for the development of biological substitutes. The overall goal is the repair and/or regeneration of tissues 20 
or organs to resolve major health related concerns in humans. Multiple disciplines, such as cell biology, 21 
biomaterial research and biomedical engineering  have contributed to the advances of tissue engineering 22 
technologies. Any tissue engineering approach is composed of three major components: (1) cells, (2) 23 
biocompatible scaffolds, and (3) suitable biochemical (e.g. growth factors) and physical (e.g. cyclic 24 
mechanical loading) stimuli supporting tissue formation in vitro and in situ [1]. While the engineered 25 
living substitute develops, the biocompatible scaffold should degrade without leaving remnants in the 26 
body, requiring a so-called biodegradable starter matrix (scaffold).  27 
A variety of synthetic biodegradable polymers has been investigated as TE scaffold materials, though 28 
the main disadvantage of these materials is their lack of functional groups [2, 3]. This results in limited 29 
capacity to combine with bioactive elements to reinforce their cell affinity [3]. In general, functional 30 
synthetic polymers have unsaturated bonds [4], or functional groups such as hydroxyl [5], carboxyl [6], 31 
and amide [7], through which functional biomaterials can be chemically modified by biomolecules to 32 
improve their bioactivity [5]. Nonetheless, synthetic polymers have been extensively used for TE, given 33 
their high durability, flexibility, and mechanical strength [8]. In addition, production conditions of 34 
synthetic polymers can be tightly controlled, hence making mechanical and physical properties of the 35 
material predictable, reproducible and precisely defined [9]. These characteristics make synthetic 36 
polymers to an interesting raw material for scaffold fabrication [8-10].  37 
In particular, poly-glycolic acid (PGA), poly-lactic acid (PLA), poly-hydroxy alkanoate (PHA), poly -38 
caprolactone (PCL) and their deriving copolymers have generated substantial interest as scaffold 39 
materials for the in vitro TE of bone, cartilage, as well as cardiovascular tissues [11-14]. PGA is most 40 
commonly used because it degrades at predictable time point and into (generally) biocompatible 41 
components [8]. Besides, the high porosity of PGA meshes permits a good diffusion, neovascularization 42 
and cellular infiltration [15]. Unfortunately, PGA meshes are biodegraded rapidly within few weeks and 43 
can therefore not withstand mechanical forces exerted to the materials and guide the shape of the 44 
bioengineered construct over longer culturing periods [15, 16]. As a result, hybrid polymers have been 45 
designed in order to combine the shape-memory and mechanical stability of slowly degrading polymers 46 
with the fast degrading properties of polymers, such as PGA [17]. For instance, combinations of PGA 47 
with polymers such as (poly-4-hydroxybutyrate) P4HB or PLA have been widely explored [8, 13, 14, 48 
18, 19]. PLA is synthesized by polymerization of lactic acid and can be eliminated through the citric 49 
acid cycle [15]. Due to the chiral nature of PLA, several distinct forms are existing: poly-L-lactide 50 
(PLLA), poly-D-lactide (PDLA) and LD racemic (PDLLA), respectively [15]. PLA can easily be 51 
processed and its degradation rates and physical/mechanical characteristics are adjustable over a wide 52 
range by using different molecular weights and copolymers [19, 20]. Also ε-caprolactone and 53 
copolymers have been studied intensely and are frequently investigated for biomedical applications [15]. 54 
Interestingly, PCL degrades very slowly in-vivo via enzymatic degradation and hydrolysis [21]. Unlike 55 
PGA and PCL, which are synthetized using chemical methods, P4HB is produced naturally by 56 
microorganisms making it more challenging to be synthesized [22]. After implantation into the body, 57 
P4HB degrades mainly by bulk hydrolysis producing 4HB, a normal component of the mammalian body 58 
[10].  59 
In 1998, Shinoka et al. reported surgical implantation of tissue engineered vascular grafts (TEVGs) in 60 
lambs, in which scaffolds were constructed from autologous cells seeded onto PGA grafts [23]. Further 61 
studies have been conducted, for instance, by using PGA-poly-L-lactic acid (PLLA) scaffolds for 62 
microvessels in mice [24] or scaffolds composed of polyglycolide knitted fiber, and an L-lactide and ε-63 
caprolactone copolymer sponge for TEVGs in a canine inferior vena cava model [25]. The hybrid 64 
polymeric scaffold fabricated from either PGA or PLA fiber-based mesh coated with a 50:50 copolymer 65 
of L-lactide and ε-caprolactone (PCLA/PGA or PCLA/PLA) are more elastic than the PGA scaffold 66 
[26]. This results in an improved compliance match between the vessel and the conduit and ultimately 67 
in better surgical handling characteristics [26]. For both heart valve and vascular tissue engineering the 68 
use of PGA meshes coated with P4HB, meaning the combination of the thermoplastic characteristic of 69 
P4HB and the high porosity of PGA meshes, has been investigated intensively with promising results 70 
in vitro and in preclinical studies [27-29]. In 2006, Hoerstrup et al. provided the first evidence of living, 71 
functional pulmonary arteries engineered from vascular cells seeded on PGA/P4HB scaffolds in a 72 
growing lamb model [13]. In contrast, PCL has been mainly investigated for biomedical applications in 73 
bone and cartilage repair, as surgical suture as well as for drug delivery systems, especially those with 74 
longer working lifetimes [12, 15]. Lee et al. showed that a PCL/ poly(methyl methacrylate) (PMMA) 75 
scaffold was suitable for cell growth in vitro and for new bone formation in vivo [30]. This study 76 
suggested that PCL/PMMA blends can be used for biopolymer composite scaffolds in bone tissue 77 
engineering [30]. In general, all polyesters are biocompatible and have formed the bases of numerous 78 
FDA approved medical devices for clinical use [9, 31]. 79 
However, in spite of their frequent use in biomedical research and therapeutic products, there is still a 80 
lack of systematic comparative analyses, such as qualitative and quantitative assays of tissue formation 81 
and biomechanics between different synthetic polymers. Therefore, the present study aims at a 82 
systematic, multimodal comparison of three frequently used polymers (PGA, PLA, PCL) integrated into 83 
a co-polymer solution with P4HB for the in vitro engineering of extracellular matrix under static as well 84 
as dynamic conditions. These data might allow for a specific selection of a certain polymer starter 85 
matrices aiming at specific tissue properties of bioengineered materials in vitro. 86 
 87 
Material and Methods 88 
 89 
1 Isolation and culture of human umbilical cord fibroblasts 90 
Human umbilical cords (n=3) were collected after full-term births with informed consent according to 91 
the cantonal ethics commission of Zurich, Switzerland [KEK-ZH-2009-0095] and processed for 92 
isolation of venous fibroblasts according to established protocols [32]. Briefly, the umbilical cord vein 93 
was isolated surgically and small tissue pieces were cut out using a dissecting scissors. Tissue pieces 94 
were placed on a sterile petri dish and were left to adhere to the bottom for 20min. Culture medium 95 
containing DMEM high glucose (Sigma-Aldrich, Switzerland), 10% fetal bovine serum (Biowest, USA) 96 
and an antibiotic/antimitotic solution (Sigma-Aldrich, Switzerland), was gently added and changed 97 
every third day. Tissue pieces were removed after first cellular outgrowth after approximately 1-2 weeks 98 
of incubation under humidified incubator conditions at 5% CO2 at 37 °C. Three different fibroblast cell 99 
lines (named B014, B015 and B020) were isolated.  100 
 101 
2 Phenotyping of human fibroblasts 102 
Isolated human cells (n=3) were characterized using immunofluorescence staining for common 103 
myofibroblast markers. Therefore, cells were cultured on 3.5 cm2 cell culture dishes, fixed with 4% 104 
paraformaldehyde (Sigma-Aldrich, Switzerland), and incubated over night at 4°C with the following 105 
primary antibodies: alpha smooth muscle actin (1A4, Abcam, United Kingdom), Vimentin (Vim 3B4, 106 
Abcam, United Kingdom), CD90 (EPR3133, Abcam, United Kingdom), CD31 (JC70A, Dako, USA), 107 
and Phalloidin (Life Technologie, Switzerland). The following secondary antibodies were used: anti 108 
mouse  Alexa Flour 488 (Invitrogen, USA) and anti rabbit Alexa Flour 488 (Invitrogen, USA) and Dapi 109 
(Sigma-Aldrich, Switzerland). Cells were analyzed with a DM6000B fluorescence microscope (Leica, 110 
Germany). Image processing was performed using the Leica software (Leica, Germany). 111 
 112 
3 Proliferation assay 113 
Cellular proliferation was assessed by determining the number of total cells based on the absorbance of 114 
crystal violet when cultured on a 24-well plate for up to 7 days. In brief, every day cells were fixed with 115 
methanol (Sigma-Aldrich, Switzerland) for 10 minutes and stained with 0.1% crystal violet (Artechemis, 116 
Switzerland) for 5 minutes. The 24-well plates were washed and air-dried. Cells were solubilized with 117 
2% Na-deoxycholat (Sigma-Aldrich, Switzerland) while being heated at 60°C for 10min. The 118 
absorbance was analyzed at 550nm using a standard ELISA reader Synergy HT (Bio TEK, USA). To 119 
obtain quantitative information a standard curve with serial dilutions was performed.  120 
 121 
4 Surface morphology of biomaterials 122 
Samples were mounted on electron imagining stubs using carbon tape and subsequently sputter coated 123 
in 5nm of Pt/Pd (Quorum Technologies, EMS 300TD, USA) to reduce fiber degradation during imaging. 124 
A field emitting electron microscope was used to image samples at 15 kV power (Zeiss, FESEM Ultra 125 
Plus) for clarity. For each sample, four regions of interest (ROI) measuring 1000 x 800 um were imaged 126 
from which five fibers per ROI were measured using Image J software (NIH, v1.48s, line tool) to 127 
determine the average fiber diameter of an ROI. For scaffold porosity, an additional four ROIs 128 
measuring 3000 x 2250um were imaged. Each porosity ROI image was then automatically thresholded 129 
in Image J and porosity was defined as the percent area that was non-fiber (ie empty/porous space).   130 
 131 
5 Tissue Engineering 132 
 133 
5.1 Scaffold fabrication 134 
Patches were fabricated from non-woven polyglycolic acid (PGA) meshes (thickness 1.0 mm; specific 135 
gravity 70 mg/cm3; Cellon, Luxembourg) and coated with either 1% poly-4-hydroxybutyrate (P4HB; 136 
TEPHA, Inc., USA) or 1% Poly(L-lactide (PLA, Carbion, USA)  or 1% polycaprolactone (PCL, 137 
Carbion, USA) by dipping into a tetrahydrofuran solution (Sigma-Aldrich, Switzerland). After solvent 138 
evaporation and vacuum drying overnight, the scaffolds were placed into a 70% EtOH (Sigma-Aldrich, 139 
Switzerland) for 30 min to obtain sterility, followed by two washing cycles with PBS (Sigma-Aldrich, 140 
Switzerland). Thereafter, scaffolds were pre-incubated in DMEM culture medium previously described 141 
for 12–24 hours to facilitate cell attachment. 142 
 143 
5.2 Cell seeding 144 
Human fibroblasts (n=3) were seeded onto scaffolds using a density of 1.5*106cells/cm2. Therefore, 145 
fibrinogen (Sigma-Aldrich, Switzerland) (10 mg/mL of active protein) and thrombin (Sigma-Aldrich, 146 
Switzerland) were prepared, used and titrated to an optimal clotting time of approximately 30sec by 147 
adapting the concentration of fibrinogen. The cells were resuspended in a fibrinogen-thrombin co-148 
solution and subsequently seeded onto the sterile scaffolds. After static incubation of seeded constructs 149 
in DMEM (10% fetal bovine serum; penicillin/streptomycin and 0.9mM of L-ascorbic acid-2-phosphate 150 
(Sigma-Aldrich, Switzerland)) for 7 days, they were kept either under static conditions or placed onto a 151 
shaker for additional mechanical stimulation via shear stress. The constructs were harvested after 21 152 
days of culture and processed immediately for subsequent analyses 153 
 154 
6 Qualitative Tissue Analysis 155 
For immunohistochemical analysis of TE patches (n=3 per group), sections with 5µm thickness derived 156 
from blocks of formalin-fixed, paraffin-embedded tissue were mounted on glass slides (SuperFrost Plus, 157 
Menzel Gläser,Germany), deparaffinized, rehydrated and stained with hematoxylin and eosin (H&E) or 158 
Masson Trichrome using standard histological techniques. All sections were analyzed using a Mirax 159 
Midi BF slide scanner (Zeiss, Germany) and processed using MIRAX viewer (Zeiss, Germany).  160 
 161 
7 Quantitative Tissue Analysis 162 
TE patches (n = 6 per group) were minced, lyophilized, and analyzed using biochemical assays for total 163 
deoxyribonucleic acid (DNA) content as an indicator for cell number, hydroxyproline (HYP) content as 164 
an indicator for collagen, as well as for glycosaminoglycan (GAG) content. All TE patches were 165 
digested in papain (Sigma-Aldrich, Switzerland) solution (300 µg/mL in PBS with 5mM EDTA (Sigma-166 
Aldrich, Switzerland) and 5mM cysteine (Sigma-Aldrich, Switzerland), at 65°C for 16 hours. For 167 
measuring the cellularity of the constructs, the DNA amount was quantified according to manufacturer’s 168 
protocol (Life Technologies, Switzerland, No. P11496). The GAG content was determined using a 169 
modified version of the protocol described by [33], and a standard curve prepared from chondroitin 170 
sulfate from shark cartilage (Sigma-Aldrich, Switzerland). Hydroxyproline was determined with a 171 
modified version of the protocol provided by [34]. Remnants of the hybrid polymers matrices were 172 
visualized using polarization microscopy (Zeiss, Germany). 173 
 174 
8 Biomechanics 175 
After 0 (only for the unseeded group) and 21 days of culture, the mechanical properties of the TE 176 
constructs (n = 4 per group) were assessed using a uniaxial tensile tester (Instron 5864, Boston, MA, 177 
USA) equipped with a 100-N load cell. For comparison, native tissues (cartilage, skin and vein) were 178 
harvested from sheep post mortem provided by the local slaughterhouse Zurich/Hinwil, Switzerland 179 
(n=4). The crosshead speed was set to correspond to an initial strain rate of 7mm/min and the tester 180 
operated at 5bars of air pressure. Patches had a cross-sectional area of 14mm x 4mm x 1 mm (length x 181 
width x thickness) and were fixed with hydraulic clamps. Stress–strain curves were obtained and 182 
Young’s modulus was determined as the slope of the curve at a strain of 10%, as a measure for tissue 183 
stiffness. 184 
 185 
9 Statistic 186 
Quantitative data are presented as mean ± standard deviation. For statistical comparison of the 187 
proliferation rate of the three different cell lines a one-way ANOVA was performed and p-values < 0.05 188 
were considered statistically significant. Surface morphology measurements were statistically analyzed 189 
by non-parametric Mann-Whitney-U-test and p-values < 0.05 (corrected post hoc according to 190 
Bonferroni) were considered statistically significant. In addition, quantitative tissue analysis and 191 
biomechanics were statistically evaluated by an unpaired students-t-test and p-values p < 0.05 (corrected 192 
post hoc according to Bonferroni) were considered statistically significant. KS normality test was used 193 
to confirm normal distribution of the dataset (p > 0.05). All statistical analyses were performed using 194 
the GraphPad Prism 5 software (GraphPad Software Inc., USA). 195 
 196 
Results 197 
 198 
Phenotype and proliferation of umbilical cord derived fibroblasts 199 
Immunofluorescence performed on fibroblasts derived from three different patients revealed that all cell 200 
types displayed similar immunophenotypic patterns. Isolated human fibroblasts expressed myogenic 201 
markers, such as alpha smooth muscle actin and vimentin, and common fibroblast marker CD90 (Figure 202 
1a). 203 
 204 
 205 
Figure 1: Phenotypic characterization and proliferation of isolated fibroblasts.  206 
a) Immunohistochemical analyses of three different human fibroblast cell lines (B014, B015 and B020) revealed positive 207 
expression of alpha smooth muscle actin, Vimentin and CD90 (Phalloidin in red, Dapi in blue and respective antibody in green). 208 
All three markers showed a homogenous expression pattern. Fibroblasts were negative for the endothelial cell surface marker 209 
CD31. b) Cell number was determined over one week for all three cell lines using the crystal violet-based proliferation assay. 210 
No significant differences were detected. (Scale bars: 50 µm)  211 
 212 
In contrast, the cells were negative for the endothelial cell surface marker CD31 excluding non-213 
fibroblastic contamination during cell isolation procedures. In the proliferation analysis based on crystal 214 
violet staining (Figure 1b), no significant differences in proliferation parameters were detected between 215 
the three fibroblast lines when considering cell numbers over 7 days (p<0.05). These findings exclude 216 
potential significant inter-individual proliferation differences. 217 
 218 
Surface morphology of biomaterials 219 
Microstructural analysis using scanning electron microscopy (SEM) was used to analyze the fiber size 220 
and porosity of unseeded polymers before and after coating (Figure 2a-d and f-i) (n=4 per condition). 221 
 222 
Figure 2: Surface and intersection morphology of biomaterials. Scanning electron micrographs (SEM) show the fiber 223 
alignment and size of unseeded biomaterials. a-d) SEM of the surface f-i) SEM of the cross section e) The fiber diameter was 224 
consistent among all biomaterials. (n=4) j) PGA-PCL was significantly less porous than PGA-P4HB or PGA-PLA. PGA-P4HB 225 
and PGA-PLA showed a similar porosity. (n=4) (Scale bars: 100 µm)  226 
 227 
The PGA-PCL matrix (Figure 2a and f) was less porous in comparison to the hybrid polymers PGA-228 
P4HB (Figure 2b and g), PGA-PLA (Figure 2c and h), and PGA (Figure d and i). Quantitative 229 
measurements of the porosity confirmed these differences (Figure 2j). PGA-PCL scaffolds were 230 
significantly less porous than PGA-P4HB (p<0.05) or PGA-PLA (p<0.05) scaffolds. PGA-P4HB and 231 
PGA-PLA scaffolds showed a similar porosity with no significant difference (p=0.69). Uncoated PGA 232 
mesh was significant more porous in comparison to PGA-P4HB (p<0.05), PGA-PLA (p<0.05), and 233 
PGA-PCL (p<0.05). The fiber diameter was uniform among all biomaterials with no statistically 234 
significant differences between different hybrid polymer groups or uncoated PGA (Figure 2g, p<0.05) 235 
(Figure 2e). Imaging of the surface (Figure a-d) and cross section (Figure f-i) display the distribution of 236 
the coating compared to PGA scaffold only. The different hybrid polymer present a similar distribution 237 
of the coating. In general, there was more coating visible on the outer scaffold regions, while in the 238 
central part of the scaffold less was detected. 239 
 240 
Qualitative Tissue Analyses 241 
Microstructural features of human fibroblast-derived TE patches were analyzed by histological staining 242 
procedures (Figure 3) as well as polarization microscopy (Figure 4).  243 
H&E staining demonstrated formation of extracellular matrix (ECM) in vitro with high cellularity and 244 
layered tissue on the outer scaffold regions, while in the central part of the scaffold low cellularity and 245 
no significant formation of ECM were present. In order to investigate the deposition of collagen fibers 246 
Masson Trichom staining was used. In general, TE patches under dynamic conditions (Figure 3, right 247 
column) revealed more tissue formation and ECM deposition compared to static conditions. 248 
Importantly, all three cell lines exhibited comparable tissue formation for respective hybrid polymer 249 
conditions excluding a potential bias due to inter-individual differences. PGA-PCL-based patches 250 
showed for both culture conditions (dynamic and static) less tissue formation and high quantities of 251 
scaffold remnants in comparison to the PGA-P4HB or PGA-PLA. In order to confirm these findings 252 
polarization microscopy was performed to further visualize different polymer components (Figure 4).  253 
 254 
 255 
Figure 3: Histology of tissue-engineered patches under static and dynamic conditions. Hematoxylin-eosin (H&E) staining 256 
of statically cultured tissue-engineered patches (left column) revealed cellular ingrowth with tissue formation, and some 257 
collagen fibers could be detected with Masson Trichrome staining (MT). In contrast, patches cultured under dynamic conditions 258 
(right column) demonstrated more cellular tissue formation and production of extracellular matrix elements. All three cell lines 259 
displayed similar tissue formation for respective conditions/coatings. PGA-PCL patches showed for both culture conditions 260 
less tissue formation and high quantities of scaffold remnants in comparison to PGA-P4HB or PGA-PLA. (Scale bars: 200 µm) 261 
 262 
 263 
 264 
Figure 4: Polarization microscopy of tissue-engineered patches under static and dynamic conditions. Polarization 265 
microscopy revealed the presence of the initial scaffold matrix in particular in the central part of the constructs. PGA fibers are 266 
shown as elongated ellipses (high magnification). Webbings between PGA fibers represent coating remnants (low 267 
magnification). However, in the dynamic fibroblast-based constructs the biomaterial remnants were more degraded (d-f) 268 
compared with static cultures (a-c).  PGA-PCL (b, e) starter matrix showed a very strong preservation of the co-polymer when 269 
compared to PGA-P4HB (a, d) or PGA-PLA (c, f) scaffolds (scale bars: 400µm low magnification, 100 µm high magnification). 270 
 271 
The starter matrices showed no major remodeling in the central part of the constructs in static as well as 272 
dynamic conditions given the lack of tissue formation in this area of the constructs. PGA fibers were 273 
visible as elongated ellipses (Figure 4, high magnification), whereas the webbings between PGA fibers 274 
represented remnants of the coating (Figure 4, low magnification). In dynamic conditions the 275 
biomaterial was more degraded (Figure 4d-f) when compared to the static cultures (Figure 4a-c). In 276 
particular, the PGA-PCL starter matrix (Figure 4b, e) showed strong preservation of the polymer 277 
components compared to PGA-P4HB (Figure 4a, d) or PGA-PLA (Figure 4c, f). 278 
 279 
Quantitative Tissue Analysis 280 
The composition of the ECM of the human fibroblast-derived TE constructs was biochemically analyzed 281 
using assays for HYP, GAG, and the cell number (DNA) (Figure 5).  282 
 283 
 284 
Figure 5: Extracellular matrix analysis of tissue-engineered patches under static and dynamic conditions. Extracellular 285 
matrix analysis shows the amount of hydroxyproline (HYP), glycosaminoglycans (GAG), and the cell number 286 
(deoxyribonucleic acid, DNA) of tissue-engineered patches, which were statically or dynamically cultured (all values relative 287 
to control samples (ctrl) indicating biomaterials only). Generally, all three cell lines displayed similar amounts of HYP, GAG 288 
and DNA for respective conditions/coatings, no significant differences were detected. Overall PGA-P4HB (n=6) showed a 289 
higher expression of DNA, GAG, and HYP in comparison to PGA-PLA (n=6) or PGA-PCL (n=6).  290 
 291 
 292 
The expression level of DNA, GAG, and HYP is for all 3 coatings higher under dynamic conditions 293 
than under static conditions. Analyses were performed after three weeks of static or dynamic culture. In 294 
general, no significant differences were detected between the three different cell lines relating to 295 
expression of HYP, GAG and DNA for respective coatings under static or dynamic conditions, 296 
indicating no inter-individual differences. In total, six TE patches per cell line and per coating condition 297 
were analyzed. PGA-P4HB showed a significantly higher expression of DNA, GAG, and HYP in 298 
comparison to PGA-PLA (p<0.05) or PGA-PCL (p<0.05) under static conditions suggesting a more 299 
rapid formation of ECM in vitro. Moreover, PGA-PLA exhibited a significantly higher expression of 300 
DNA and HYP than PGA-PCL (p<0.05) under static conditions. Dynamically cultured PGA-PLA 301 
(p<0.05) and PGA-P4HB (p<0.05) patches expressed a significantly higher amount of DNA, GAG and 302 
HYP than PGA-PCL patches. PGA-P4HB (p<0.05) also displayed a significantly higher DNA and HYP 303 
expression than PGA-PLA. In general, the expression levels of DNA, GAG and HYP were higher for 304 
all coatings under dynamic conditions compared to statically cultured patches. 305 
 306 
Biomechanics 307 
The material properties of the different TE patches used in this study were determined via uniaxial 308 
tensile tests in comparison to native ovine tissue, such as cartilage, skin and vein (Figure 6). Stress–309 
strain curves were obtained and Young’s modulus was determined as the slope of the curve at a strain 310 
of 10%, as a measure for tissue stiffness. Contribution of tissue formation to the mechanical properties 311 
was observed in all TE patches, given a higher elasticity with culture time in comparison to unseeded 312 
control. Due to the rapid loss of mechanical integrity of the scaffold, biomechanical tests on the TE 313 
patches under dynamic conditions over time could not be performed. Overall, PGA-PLA and PGA-314 
P4HB TE patches show similar biomechanical properties. Both conditions display tensile stress of about 315 
0.02MPa and strain at maximal stress of about 20%. Tensile moduli of both 0.04MPa and 0.08MPa were 316 
obtained, which were not significantly different (p=0.1479). In case of PGA-PCL, tensile stress was 317 
0.54MPa, tensile strain was 8%, and having a Young`s modulus of 4MPa respectively. Generally, PGA-318 
PCL showed a significantly higher Young`s modulus, tensile strength and lower strain at maximal stress 319 
compared to PGA-PLA (p<0.05) or PGA-P4HB (p<0.05). For a better interpretation of the obtained 320 
results, also native ovine tissue were analyzed biomechanically. For cartilage, Young’s modulus was 321 
about 35MPa, tensile strength was 12MPa, and strain at maximal stress was 32.5%. In addition, skin 322 
had a Young`s modulus of 0.005MPa, tensile stress of 14.5MPa and tensile strain of 160%. Similar 323 
results were found for the vein with a Young`s of 0.0054MPa, a tensile stress of 2MPa and tensile strain 324 
of 185%. 325 
 326 
  327 
Figure 6: Mechanical properties of tissue-engineered patches and native tissue. Stress–strain curves were obtained and 328 
Young’s modulus was determined as the slope of the curve at a strain of 10%, as a measure for tissue stiffness. Control (ctrl) 329 
means biomaterials only. Generally, PGA-PCL (n=12, 4 patches per group) showed a significant higher Young`s modulus, 330 
tensile strength and lower strain at maximal stress compared to PGA-PLA (n=12) or PGA-P4HB (n=12). As a comparison 331 
cartilage, skin and vein samples (n=4) were also tested. 332 
Discussion 333 
The tissue formation produced by implanted cells is highly influenced by the scaffold onto which they 334 
are seeded. Different types of biodegradable polymers as a scaffold have been investigated for tissue 335 
regeneration, such as PGA, PLA, P4HB and PCL [8, 10, 20]. Therefore, the present study aimed at a 336 
systematic, multimodal comparison of three frequently used polymers for the in vitro engineering of 337 
extracellular matrix under static as well as dynamic conditions.  338 
So far, most biomaterials do not completely mimic physiological microenvironment and can therefore 339 
not enable native like cellular interaction and behavior [15]. Blending two polymers has gathered 340 
growing interest for constructing native-like tissues [15]. Thus, patches were cut from PGA meshes and 341 
coated with same concentrations of either P4HB, PLA, or PCL. In addition, to mimic the native tissue 342 
and serving as an artificial environment, the structure and surface morphology of the scaffolds have to 343 
meet general requirements: (I) pores to ensure cell growth and nutrients/ metabolic waste transport; (II) 344 
three-dimensional architecture; (III) suitable mechanical properties depending on the native tissue to be 345 
replaced; (IV) suitable surface chemistry; (V) biodegradation and bioresorbability [35]. Moreover, pore 346 
size affects cell binding, migration depth of cellular in-growth, cell morphology, and phenotypic 347 
expression [36].  348 
For this reason, we performed SEM to analyze the ultra-structure of the unseeded scaffold. SEM 349 
confirmed the uniform fiber diameters of the coated PGA matrix. In contrast, PGA-PCL scaffolds were 350 
significantly less porous than PGA-P4HB or PGA-PLA scaffolds. PGA-P4HB and PGA-PLA scaffolds 351 
showed a similar porosity. These findings already suggested a potential improved cell infiltration and 352 
consequent tissue formation for PGA-P4HB and PGA-PLA in comparison to PGA-PCL. For example, 353 
porosity of the scaffold plays an important role in bone and cartilage regeneration [37, 38]. Interestingly, 354 
lower porosity enhances osteogenesis by suppressing cell proliferation and forcing cell aggregation in 355 
vitro [38]. In contrast, higher porosity and larger pore size lead to greater bone ingrowths to the scaffold 356 
but diminish the mechanical properties in vivo [38]. However, one has to take into account that for 357 
comparative issues the concentrations of P4HB, PLA, and PCL were consistent and could be further 358 
adapted for specific requirements. 359 
Hence, microstructural features of human fibroblast-derived TE patches were analyzed by histological 360 
stainings as well as polarization microscopy. In general, tissue engineered patches under dynamic 361 
conditions represented a more extensive tissue formation and ECM deposition. Wang et al. also showed 362 
an enhanced cell proliferation under dynamic three-dimensional (3D) culture compared with 363 
conventional static two-dimensional (2D) and 3D cell culture conditions [39]. In addition, high-364 
throughput microarray analysis showed that gene expressions of dynamic 3D system displayed 365 
significant differences in cell proliferation and differentiation compared with static-2D conditions [39]. 366 
Nonetheless, PGA-PCL based patches displayed less tissue formation and higher quantities of scaffold 367 
remnants in comparison to the PGA-P4HB or PGA-PLA under static as well as under dynamic 368 
conditions.  369 
In general, dynamic conditions enhanced the degradation of biomaterial in comparison to static 370 
conditions. In particular, less PGA fibers were detectable after 3 weeks of culture in comparison to the 371 
webbings between the PGA fibers, especially PGA-PCL showed particularly strong preservation of the 372 
polymer components. Different studies have proven that PGA degrades faster than P4HB, PLA and PCL 373 
[40, 41]. In addition, production conditions of synthetic polymers can be tightly controlled, hence 374 
making mechanical and physical properties well defined and predictable. For instance, the time to 375 
complete degradation and resorption of P4HB varies with size and processing, i.e., the orientation of the 376 
polymer fibers. In general, complete resorption of P4HB occurs between 12 and 18 months in vivo [40]. 377 
The characteristics of PLA are highly affected by the stereo-isomeric L/D ratio of lactate units [8]. 378 
Generally, an increased stereo-isomeric ratio decreases the crystallinity, whereby the degradation is 379 
enhanced. For example, degradation of PLA is faster than PDLA due to the lower crystallinity of PLA 380 
[8]. PLA and PCL degradation takes longer than 24 months in vivo [41]. In contrast, PGA is degraded 381 
within 4-6 months in vivo [15, 16]. The composition of the ECM of human fibroblast-derived TE 382 
constructs was analyzed and PGA-P4HB showed a significantly higher expression of DNA, GAG, and 383 
HYP in comparison to PGA-PLA or PGA-PCL under static conditions suggesting a more rapid 384 
formation of ECM in vitro. The interactions between cells and ECM are essential in cell attraction, cell 385 
differentiation and wound healing [42]. Dynamically cultured PGA-PLA and PGA-P4HB patches 386 
expressed a significantly higher amount of DNA, GAG and HYP than PGA-PCL patches. The general 387 
expression levels of DNA, GAG and HYP were higher for all coatings under dynamic conditions 388 
compared to statically cultured patches. These findings confirm and underline the findings in histology. 389 
It is proven that mechanobiological interactions between cells and scaffolds can crucially influence cell 390 
behavior [43-45]. For example, the mechanobiologic regulation of cartilage matrix biosynthesis was 391 
successfully exploited by the application of cyclic compression to constructs formed by encapsulating 392 
primary bovine chondrocytes in agarose hydrogels [45, 46]. By 28 days, determined improvements in 393 
the compressive stiffness were observed in groups that had been exposed to mechanical loading 394 
compared with free swelling controls [46]. Even though relations between these forces and cell 395 
responses are exhibited, elucidation of the mechanotransduction pathways is far from revealed. The 396 
transduction of external forces to signaling pathways involves intracellular forces and associated 397 
molecular deformations, such as gap junctions on the cell membrane, the cytoskeleton, and DNA [44, 398 
45]. 399 
Importantly, a balance between the rate of scaffold degradation and tissue formation is crucial for 400 
maintaining mechanical integrity of the replaced tissues [47]. The biodegradable scaffold should have 401 
sufficient mechanical properties (such as strength and stiffness) approximating those of the host tissue 402 
until the biodegradable scaffold matrix is substituted by the new tissue [47]. The material properties of 403 
different TE patches used in this study were determined via uniaxial tensile tests. In addition, we 404 
compared these values with native ovine cartilage, skin and vein tissue. Contribution of tissue formation 405 
to the mechanical properties was observed in all TE patches, as samples became less stiff with culture 406 
time in comparison to unseeded controls. Overall, PGA-PLA and PGA-P4HB TE patches show similar 407 
biomechanical properties. Generally, PGA-PCL showed a significant higher Young`s modulus, tensile 408 
strength and lower strain at maximal stress compared to PGA-PLA or PGA-P4HB. Meaning that on one 409 
hand PGA-PCL is stiffer and on the other hand is more robust than PGA-P4HB and PGA-PLA. Notably, 410 
in contrast to PGA-PCL, PGA-P4HB and PGA-PLA are more ductile and flexible. The values are still 411 
not in the range of native tissue but this may rely on the polymer remnants and the incomplete tissue 412 
formation in vitro. However, as with many polymers, the mechanical properties of the material depend 413 
not only on the basal material, but also on its processing history [40]. 414 
Conclusion 415 
Biodegradable synthetic polymers are an interesting raw material for scaffold fabrication and have been 416 
intensively investigated for TE. As the scaffold plays a crucial role in the successful design of TE 417 
constructs, the choice of material directly influences the outcome. Our study may allow for a specific 418 
selection of a certain polymer starter matrices aiming at specific tissue properties of bioengineered 419 
materials in vitro.  In general, we showed that PGA-P4HB coating display better tissue formation and a 420 
significant higher expression level of DNA, GAG and HYP in comparison to PGA-PLA and PGA-PCL. 421 
However, PGA-PCL is under biomechanical conditions more robust than PGA-P4HB and PGA-PLA.  422 
Future studies are required to evaluate, which combination under which conditions allows for the best 423 
tissue formation and native-like biomechanical properties. 424 
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